2015 American Transplant Congress » Poster Session C: Kidney Immunosuppression: Desensitization

Date: Monday, May 4, 2015

Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-6:30pm: Comparison of One-Year Outcomes in High Risk Kidney Transplantation: ABO Incompatible and DSA Positive/CDC-AHG Negative

N. Townamchai,¹ W. Chancharoenthana,¹ S. On-Pun,² S. Wattanatorn,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹

5:30pm-6:30pm: Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy

E. Jolly,¹ C. Taylor,² H. Morgan,² S. Peacock,² M. Clatworthy,¹ N. Torpey.¹

5:30pm-6:30pm: Desensitization Before Living Donor Kidney Transplantation in Highly Sensitized Patients

E. De Sousa,¹ I. Revuelta,¹ M. Blasco,¹ F. Diekmann,¹ J. Cid,² M. Lozano,² A. Sánchez-Escuredo,¹ J. Martorell,³ E. Palou,³ J. Campistol,¹ F. Oppenheimer.¹

5:30pm-6:30pm: Desensitization Protocol Including Concomitant Bortezomib and Rituximab Did Not Reduce Calculated PRA Nor Mean MFI Values Among Waitlisted Patients for Deceased Donor Kidney Transplantation

S. Kang,¹ H. Lim,¹ J. Jeong,¹ E. Song,² I. Yun,³ C. Ahn,¹ J. Yang.¹

5:30pm-6:30pm: Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy

K. Takahashi,¹ K. Saito,² S. Takahara,³ S. Fuchinoue,⁴ T. Yagisawa,⁵ A. Aikawa,⁶ Y. Watarai,⁷ N. Yoshimura,⁸ K. Tanabe,⁴ K. Morozumi,⁹ M. Shimazu.¹⁰

5:30pm-6:30pm: Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

S. Narumi,¹ Y. Watarai,¹ N. Goto,¹ T. Hiramitsu,¹ T. Yamamoto,¹ M. Tsujita,¹ M. Okada,¹ K. Futamura,¹ A. Takeda,² T. Kobayashi.³

5:30pm-6:30pm: Impact of Baseline and Postoperative Isoagglutinin Titer on Clinical Outcomes in ABO-Incompatible Living Donor Kidney Transplantation

E. Shin,¹ H. Cho,¹ H. Kim,¹ C. Baeck,¹ H. Yu,¹ D. Han,² S.-K. Park.¹

5:30pm-6:30pm: Infectious Complications in ABO Incompatible Kidney Transplantation Recipient According to the Rituximab Dose

J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ D. Joo,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ H. Kim,² K. Huh.¹

5:30pm-6:30pm: Interference of Therapeutic Antibodies Used in Desensitization Protocols On Lymphocytotoxicity Crossmatch Results

D. Milongo,^1,3 G. Vieu,^2,4,3 S. Blavy,^2,4 A. Del Bello,^1,3 F. Sallusto,⁵ L. Rostaing,^1,3 N. Kamar,^1,3 N. Congy-Jolivet.^2,4,3

5:30pm-6:30pm: Mesenchymal Stem Cells (MSCs) Transfusion for Desensitization of Positive Lymphocyte Cross Match (LCM) or Panel Reactive Antibodies (PRA) Before Kidney Transplantation – Outcome of 16 Cases

G. Saadi,¹ K. Eweda,² M. Hassaballa,¹ F. Fadel,³ E. Aziz,² M. Roshdi,¹ M. El Ansary,⁴ I. Aziz,⁴ W. Ismail,⁵ A. Atef,¹ S. Hamid.⁴

5:30pm-6:30pm: Post-Transplantation Immunoadsorption Can Be Safely Withheld After ABO-Incompatible Kidney Transplantation

A. de Weerd,¹ M. van Agteren,¹ J. Ijzermans,² W. Weimar,¹ M. Betjes.¹

5:30pm-6:30pm: Pre-Transplant Desensitization Protocol and Cancer Risk in Kidney Transplantation

I. Revuelta,^1,2,3 R. Ferreira,¹ C. Canha,¹ P. Piselli,⁴ D. Verdirosi,⁴ V. Tubita,² E. De Sousa,¹ F. Diekmann,^1,2,3 M. Lozano,^2,5 J. Cid,⁵ E. Palou,⁶ J. Martorell,⁶ A. Alcaraz,⁷ D. Serraino,⁸ F. Oppenheimer,^1,2,3 J. Campistol.^1,2,3

5:30pm-6:30pm: The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant

J. Benken,¹ S. Akkina,² E. Benedetti.³

« View all sessions from the 2015 American Transplant Congress